Cargando…
Identification of New Vulnerabilities in Conjunctival Melanoma Using Image-Based High Content Drug Screening
SIMPLE SUMMARY: We determined the sensitivity of several conjunctival melanoma cell lines to kinase inhibitors as well as a few other inhibitors using an image-based high throughput drug screening assay with 542 compounds. All cell lines demonstrated sensitivity to cell cycle inhibition, especially...
Autores principales: | Nardou, Katya, Nicolas, Michael, Kuttler, Fabien, Cisarova, Katarina, Celik, Elifnaz, Quinodoz, Mathieu, Riggi, Nicolo, Michielin, Olivier, Rivolta, Carlo, Turcatti, Gerardo, Moulin, Alexandre Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946509/ https://www.ncbi.nlm.nih.gov/pubmed/35326726 http://dx.doi.org/10.3390/cancers14061575 |
Ejemplares similares
-
5-Hydroxymethylcytosine Loss in Conjunctival Melanoma
por: Stahl, Alexandre, et al.
Publicado: (2021) -
Genomic and transcriptomic landscape of conjunctival melanoma
por: Cisarova, Katarina, et al.
Publicado: (2020) -
β-Catenin Expression and Activation in Conjunctival Melanoma
por: Larivé, Emerentienne, et al.
Publicado: (2019) -
A high-content image-based drug screen of clinical compounds against cell transmission of adenovirus
por: Georgi, Fanny, et al.
Publicado: (2020) -
High-throughput, nonperturbing quantification of lipid droplets with digital holographic microscopy
por: Campos, Vasco, et al.
Publicado: (2018)